Petros Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $2.1M |
| Mar 2020 | — | — | $1.1M |
| Jun 2020 | — | — | $831.8K |
| Sep 2020 | — | — | $669.1K |
| Dec 2020 | $52.4M | $69.9M | $17.1M |
| Mar 2021 | $45.2M | $66.2M | $14.6M |
| Jun 2021 | $37.2M | $56.7M | $11.0M |
| Sep 2021 | $34.2M | $52.0M | $8.1M |
| Dec 2021 | $31.8M | $67.4M | $23.8M |
| Mar 2022 | $20.1M | $55.9M | $17.7M |
| Jun 2022 | $16.8M | $51.0M | $13.3M |
| Sep 2022 | $17.0M | $37.7M | $11.2M |
| Dec 2022 | $15.7M | $32.4M | $9.4M |
| Mar 2023 | $15.1M | $30.6M | $8.3M |
| Jun 2023 | $15.8M | $28.7M | $7.4M |
| Sep 2023 | $31.9M | $38.9M | $18.0M |
| Dec 2023 | $21.3M | $33.8M | $13.3M |
| Mar 2024 | $19.6M | $30.3M | $11.1M |
| Jun 2024 | $16.0M | $25.2M | $7.5M |
| Sep 2024 | $17.6M | $20.7M | $3.9M |
| Dec 2024 | $18.1M | $10.6M | $1.7M |
| Mar 2025 | $27.2M | $17.6M | $8.9M |
| Jun 2025 | $2.9M | $7.4M | $7.3M |
| Sep 2025 | $2.8M | $6.1M | $6.1M |
| Dec 2025 | $2.3M | $5.2M | $5.1M |
| Mar 2026 | $2.6M | $4.4M | $4.4M |
| Jun 2026 | $2.8M | $3.5M | $3.5M |